These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5472233)

  • 41. Treatment of diabetes with oral hypoglycemic drugs.
    Moss JM; DeLawter DE
    GP; 1966 Oct; 34(4):85-8. PubMed ID: 5912533
    [No Abstract]   [Full Text] [Related]  

  • 42. Acute and chronic studies using a new oral hypoglycemic agent, glyburide.
    Herrold JN; Tzagournis M; Skillman TG
    Metabolism; 1971 Apr; 20(4):414-21. PubMed ID: 4927607
    [No Abstract]   [Full Text] [Related]  

  • 43. [Action of instantaneous-delayed action phenformin, alone or in combined therapy, in 50 hospitalized diabetics].
    Vague J; Vague P; Jaquet P; Gerolami G
    Mars Med; 1966; 103(4):331-3. PubMed ID: 5997802
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical study with glipizide, a new oral antidiabetic drug.
    Persson G
    Diabetologia; 1973 Sep; ():348-50. PubMed ID: 4589635
    [No Abstract]   [Full Text] [Related]  

  • 45. Circadian variation of glucose, insulin and free fatty acids during the long-term use of oral hypoglycaemic agents in diabetes mellitus with special reference to glibenclamide.
    Hadden DR; Bhatia SK; Rigas A; Weaver JA; Montgomery DA
    Postgrad Med J; 1970 Dec; ():Suppl:53-7. PubMed ID: 5533298
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment with a new antidiabetic: glybenclamide].
    Madsen SN; Persson I
    Ugeskr Laeger; 1970 Jan; 132(4):143-7. PubMed ID: 5442953
    [No Abstract]   [Full Text] [Related]  

  • 47. [Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics].
    Belser F; Brögli H; Constam G; Zollikofer H
    Schweiz Rundsch Med Prax; 1970 Apr; 59(16):598-601. PubMed ID: 4997187
    [No Abstract]   [Full Text] [Related]  

  • 48. Experience with phenylethylbiguanide (DBI) tablets and timed-disintegration capsules (DBI-TD) administered as an adjunct to insulin or sulfonylurea drugs in previously treated diabetic patients.
    Jakobson T; Kahanpää A; Berglund B
    Ann Med Intern Fenn; 1965; 54(3):109-16. PubMed ID: 5854020
    [No Abstract]   [Full Text] [Related]  

  • 49. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical evaluation of glypidizine, a new oral hypoglycemic agent].
    Domingo Gutiérrez AJ; Fernández-Cruz A
    Rev Iber Endocrinol; 1973; 20(117):289-303. PubMed ID: 4581992
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect and tolerance of HB 419 in out-patient treated diabetics].
    Bauer G; Kloppe W; Schubert PU
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1434-6. PubMed ID: 5394467
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral hypoglycemic agents.
    Med Lett Drugs Ther; 1970 Jan; 11(2):5-7. PubMed ID: 5421186
    [No Abstract]   [Full Text] [Related]  

  • 53. Tolinase--a new oral antidiabetic drug.
    Med Lett Drugs Ther; 1966 Sep; 8(19):77-8. PubMed ID: 5971398
    [No Abstract]   [Full Text] [Related]  

  • 54. Organic acids in the blood and urine of patients with diabetes mellitus.
    Hemmingsen L; Storgaard L
    Dan Med Bull; 1973 Oct; 20(5):150-5. PubMed ID: 4770768
    [No Abstract]   [Full Text] [Related]  

  • 55. [Experiences with sulfonylurea tolazamide in an out-patient clinic for diabetics].
    Kanzler G; Trenkner G; Rausch-Stroomann JB
    Arzneimittelforschung; 1968 Oct; 18(10):1345-8. PubMed ID: 5756166
    [No Abstract]   [Full Text] [Related]  

  • 56. Blood lactate and pyruvate levels in diabetic patient treated with sulphonylureas with and without biguanides.
    Sitprija S; Vajanamarhutue C; Bunnag S
    J Med Assoc Thai; 1982 Feb; 65(2):63-71. PubMed ID: 7077214
    [No Abstract]   [Full Text] [Related]  

  • 57. Experience with glibenclamide in three diabetic clinics.
    Brearley BF; Fawcitt RA; Hirst J
    Postgrad Med J; 1970 Dec; ():Suppl:60-2. PubMed ID: 5533300
    [No Abstract]   [Full Text] [Related]  

  • 58. The management of diabetes. Installment 6: Further considerations in the use of the sulfonylureas and phenformin.
    Am Fam Physician GP; 1970 Oct; 2(4):113-27. PubMed ID: 5273255
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical report of the experience in therapy with oral antidiabetic agent HB 419].
    Leubner H
    Wien Klin Wochenschr; 1969 Sep; 81(36):625-8 passim. PubMed ID: 4897449
    [No Abstract]   [Full Text] [Related]  

  • 60. Preliminary experience with glyburide (HB-419).
    Blechman MG
    Curr Ther Res Clin Exp; 1970 Aug; 12(8):520-3. PubMed ID: 4988839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.